POMPANO BEACH, FL / ACCESSWIRE / October 17, 2023 / BioStem Technologies Inc. (OTC PINK:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announced that it will highlight the advantages of its Vendaje® and AmnioWrap2TM portfolios to help patients with difficult to heal chronic wounds at the 2023 Symposium on Advanced Wound Care (SAWC) Fall Conference held November 3rd - 5th in Las Vegas, Nevada.
"We are thrilled to attend the 2023 SAWC Fall Conference this year. This is the first year that we are exhibiting, and it is a great opportunity for us to spotlight our portfolio and scientifically demonstrate how using our BioREtain® process makes a differentiated product that not only better retains key factors such as extracellular matrix, growth factors and anti-inflammatory cytokines, but is effective to help stalled wounds such as Diabetic Foot Ulcers (DFUs) and Venous Leg Ulcers (VLUs), to heal," said Jason Matuszewski, CEO of BioStem Technologies, Inc.
Attendees should visit the BioStem exhibit hall booth (#645) to learn more about the Vendaje and AmnioWrap2 product portfolios. BioStem representatives will be available to discuss product applications and benefits to fit the needs of hospitals, clinics and private practices.
The booth will be open during the following hours:
Friday, November 3 - 4:45-6:45 p.m.
Saturday, November 4 - 12:30-3:00 p.m.
Sunday, November 5 - 12:30-2:00 p.m.
For more information, sign up @ www.biostemtechnologies.com/biostem-form
